We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.40 | 1.30 | 1.70 | - | 0.00 | 07:30:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.00 | 1.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/4/2018 10:19 | Lol ! Doubt it's JC mate. Just the time has come and it's coming together nice. I'm with stig on this one. This could get to 12p pretty easy, through that onto 20-25p if it gets through that, it's anyone's game. Pin the donkey from 33p right the way to £2.50p if you believe charts! Imo | margic | |
19/4/2018 10:17 | Attaboy JC. He is at it again. Good job disguising your buys at 150k rather than 100k. Remember keep it below 3%. Buy up to 1.7m. You should be making 20 to 30% profit | spacedust | |
19/4/2018 10:00 | It's all there on a plate. Expect this to shoot into 50-100p range once people who can do research AND analysis wake up to this | the stigologist | |
19/4/2018 09:39 | This and val look set to blow imo. Wonder if it's related to predictive therapy. Seems to be a rage right now. | margic | |
19/4/2018 09:38 | At this point in the business one of the biggest differences to PYC and most other stocks is they don't need money, this year they will become a profitable business, they have access to free funding, projects on the go and results about to arrive from many different angles. All deals are pure gravy from here. Technology that's proving it works in a huge and valuable market, right clients, right guys on board, right place to carry out business with a leading university. Any deal over £1m in a year say is game changing here. I believe there are far far more significant deals we may see PYC get themselves into. Or not if bought out!Market cap here is crazy low, consider the patents and the tech, the deals in place and the years of grafting and building the name. We get to buy with 10 years + of hindsight with the company still sitting a low in value compared....Dyor | margic | |
19/4/2018 09:03 | AACR event must have gone great. Transformational.... . | spacedust | |
18/4/2018 23:49 | Why won't you answer? What made you give up on the supposed Unicorn that was VRS? | festario | |
18/4/2018 22:41 | Leveraging Public/Private Investment – Introducing the Precision Medicine Investment Accelerator The UK is in a unique position to lead the Global Precision Medicine revolution through investment in key areas of business-led innovation. There is a significant unmet clinical need for accurate diagnosis of disease to inform patient management and choice of therapy coupled with a wealth of exciting and novel technology approaches in UK SMEs. Following the successful pilot Investment Accelerator Programme last year - where Innovate UK partnered with a small group of investors to provide simultaneous grant and investment - they are very excited to be launching a similar Investment Accelerator in Precision Medicine. Innovate UK is therefore inviting UK-based investors to partner with them to provide simultaneous grant and investment for UK SMEs operating in the field of Precision Medicine. The programme will provide 100% of the total project costs, between £500K and £1.5m, for early-stage SMEs that have real potential for growth. Innovate UK are looking for investors who in addition to capital, will accelerate growth by providing wider business skills, experience, market access and influence. Innovate UK warmly invite you to attend their workshop in the Bourgogne Suite during BioTrinity on Weds 25th April between 14:00- 15:00 where they will launch the competition and invite investors to apply to become Investor Partners on the programme. Please join them to hear detailed technical scope and the process for applying to co-invest with Innovate UK. Target Audience: Equity providers (including charities or trusts with a UK office) interested in partnering with Innovate UK to co-invest in UK based SMEs who are developing game-changing Precision Medicine Technologies. | the stigologist | |
18/4/2018 20:00 | It's tragic how Stig/Jack will try and ramp anything. 'We met potential customers'....everyo | davevt | |
18/4/2018 15:35 | How many people are nursing losses on this pile of dogshte | spacedust | |
18/4/2018 15:22 | I can smell cow pat. Do you think hedges are stupid and don't want to make money? | spacedust | |
18/4/2018 15:08 | I wonder what connects BioTrinity + Innovate UK + Precision Medicine Hmm... me can smell some SUBSTANTIAL NON-DILUTIVE FUNDING | the stigologist | |
18/4/2018 14:24 | I see JC at it again. Monday bought 200k shares at 5.25p then sold following day around 6p. Making 15% which is 1.5k in less than 24hrs. Not bad. Well done JC | spacedust | |
18/4/2018 11:39 | Or are these investors not interested in making money from a no brainer. He is just 0n holiday to do 5mins presentation. Sp is all that matters | spacedust | |
18/4/2018 11:24 | Haha. Thanks for the top. This is what I found out America 5 min slot Jim staying in for week or so Says a lot.... Go for holiday Paid by milking cow Do 5mins work As for something brewing.....nothing is otherwise we would be 500% up. Hedges would be in this. Multi millionaire investors would be buying. | spacedust | |
18/4/2018 11:21 | PYC - this is all about to get very very exciting and very exponential PYC have already achieved a MULTIPLE increase in Revenues so far this year but still attracting massive new clients and lots more Growth is going to be exponential here and people still don't get it PYC £3m SLP $300m CER $850m Physiomics PLC 16h @Physiomics is currently at #AACR2018 in Chicago, with an estimated 23k attendees from industry and academia. Both the company's stand and poster presentation have been well attended. We've met with a number of existing and potential new customers! | the stigologist | |
18/4/2018 10:59 | Being held in the 'Windy City'Last day was yesterday and people still hanging around today for meet ups at local venues. Don't know if Jim and the lads have stayed on.A sounds like they did very very well there indeed. My contact meet them and was very impressed. Says they are onto something and there was certainly many mentioning PYC at the event. Seems like they have sparked some very high interest in what they are doing and also that it's relevant to the main topics which has aided there presence there.Now let's see what comes out of this and how soon we will hear. My view is pharmas move very quick to strike deals and most have teams in place just for this. Ex glaxo man, and present glaxo man all with PYC at the event. Glaxo representing with PYC tells you all you need to know. Stigs rumours on glaxo have real backing now. One of if not the biggest event and PYC have glaxo standing by their side. Not sure if that happened at the last 3000 events they attended but that certainly adds credibility when you are there to have a majors current or ex's working with you. Doubt it was their first attendance and I'm sure they knew many faces their. Let's see the power of Jim's wand now! | margic | |
18/4/2018 10:12 | Any ideas anyone???? | spacedust | |
18/4/2018 09:06 | Where is AACR bring held? How long is jim staying there for? Jim has 5 min Slot? | spacedust | |
17/4/2018 23:16 | great tweet from Physiomics tonight | the stigologist | |
17/4/2018 22:18 | Following is a Fake item about Merck 2024 Items 18 and 19 worth reading. Translational Data Science at Merck Chris L. Waller, Ph.D. Executive Director and Head, Scientific Modeling Platforms… | myamay16 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions